Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-03-28 21:17 | English | 3.4 MB | |||
| 2019-03-07 08:02 |
Pharming Group Reports Strong Preliminary Financial Results for 2018 including …
|
English | 194.9 KB | ||
| 2019-02-25 08:24 |
Pharming announces abstract presented at the American Academy of Allergy, Asthm…
|
English | 129.0 KB | ||
| 2019-01-23 08:51 |
Pharming announces abstracts presented at The Western Society of Allergy, Asthm…
|
English | 128.9 KB | ||
| 2018-12-07 08:22 |
Pharming reports favourable conclusion from first investigator-initiated direct…
|
English | 133.6 KB | ||
| 2018-10-25 08:48 |
Pharming Group reports interim financial results for the first nine months of 2…
|
English | 174.0 KB | ||
| 2018-10-17 08:11 |
Pharming reports positive data from first
|
English | 136.0 KB | ||
| 2018-09-19 08:13 |
Pharming Receives Complete Response Letter from FDA
|
English | 127.8 KB | ||
| 2018-07-30 08:27 |
Pharming announces further issue of shares as employee options are exercised
|
English | 98.3 KB | ||
| 2018-07-26 14:56 | English | 587.1 KB | |||
| 2018-07-26 09:11 |
Pharming Reports on Financial Results for the First Half of 2018
|
English | 242.5 KB | ||
| 2018-06-05 08:28 |
Pharming announces Agenda for its Capital Markets Briefing to be held on 21 Jun…
|
English | 108.6 KB | ||
| 2018-05-24 07:21 |
Pharming Reports on Annual General Meeting of Shareholders
|
English | 372.9 KB | ||
| 2018-05-17 07:47 |
Pharming Group Interim Report on Financial Results for the First Quarter 2018
|
English | 191.9 KB | ||
| 2018-05-16 07:46 |
A global awareness day for a rare life-threatening condition: World HAEday, 16t…
|
English | 96.4 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
